Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose

Michael F. Egan, Richard Jed Wyatt, Thomas Hyde, Joel Kleinman

Research output: Contribution to journalArticle

Abstract

Rats treated chronically with neuroleptics develop vacuous chewing movements (VCMs), similar in some respects to tardive dyskinesia (TD) in man. The VCM syndrome was used as a model of TD to examine the ability of increased neuroleptic doses to produce long-term suppression of dyskinetic movements. The incidence and persistence of the VCM syndrome in individual rats were also assessed to look for affected and unaffected subgroups. Rats were initially treated for 15 weeks with haloperidol decanoate. For the next 21 weeks, half the group received a 50-150% increase in dose while the other half continued to receive the same dose. Animals were also followed during a 28-week withdrawal period. Total VCM ratings showed a skewed distribution, with some rats exhibiting few movements while others developed marked and persistent movements. Increasing doses did not suppress VCMs, nor did they exacerbate movements during the withdrawal period. To the extent that the VCM syndrome models TD, the absence of long-term suppression of the VCM syndrome suggests that, at this dosage range, increasing depot neuroleptic doses may not be a useful long-term strategy for TD suppression.

Original languageEnglish (US)
Pages (from-to)74-81
Number of pages8
JournalPsychopharmacology
Volume117
Issue number1
DOIs
StatePublished - Jan 1995
Externally publishedYes

Fingerprint

Mastication
Haloperidol
Antipsychotic Agents
Rodentia
Incidence
Tardive Dyskinesia

Keywords

  • Haloperidol
  • Rats
  • Tardive dyskinesia
  • Vacuous chewing movements

ASJC Scopus subject areas

  • Pharmacology

Cite this

Neuroleptic-induced vacuous chewing movements in rodents : incidence and effects of long-term increases in haloperidol dose. / Egan, Michael F.; Wyatt, Richard Jed; Hyde, Thomas; Kleinman, Joel.

In: Psychopharmacology, Vol. 117, No. 1, 01.1995, p. 74-81.

Research output: Contribution to journalArticle

@article{71431581413d4accba08bf3a03d70183,
title = "Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose",
abstract = "Rats treated chronically with neuroleptics develop vacuous chewing movements (VCMs), similar in some respects to tardive dyskinesia (TD) in man. The VCM syndrome was used as a model of TD to examine the ability of increased neuroleptic doses to produce long-term suppression of dyskinetic movements. The incidence and persistence of the VCM syndrome in individual rats were also assessed to look for affected and unaffected subgroups. Rats were initially treated for 15 weeks with haloperidol decanoate. For the next 21 weeks, half the group received a 50-150{\%} increase in dose while the other half continued to receive the same dose. Animals were also followed during a 28-week withdrawal period. Total VCM ratings showed a skewed distribution, with some rats exhibiting few movements while others developed marked and persistent movements. Increasing doses did not suppress VCMs, nor did they exacerbate movements during the withdrawal period. To the extent that the VCM syndrome models TD, the absence of long-term suppression of the VCM syndrome suggests that, at this dosage range, increasing depot neuroleptic doses may not be a useful long-term strategy for TD suppression.",
keywords = "Haloperidol, Rats, Tardive dyskinesia, Vacuous chewing movements",
author = "Egan, {Michael F.} and Wyatt, {Richard Jed} and Thomas Hyde and Joel Kleinman",
year = "1995",
month = "1",
doi = "10.1007/BF02245101",
language = "English (US)",
volume = "117",
pages = "74--81",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Neuroleptic-induced vacuous chewing movements in rodents

T2 - incidence and effects of long-term increases in haloperidol dose

AU - Egan, Michael F.

AU - Wyatt, Richard Jed

AU - Hyde, Thomas

AU - Kleinman, Joel

PY - 1995/1

Y1 - 1995/1

N2 - Rats treated chronically with neuroleptics develop vacuous chewing movements (VCMs), similar in some respects to tardive dyskinesia (TD) in man. The VCM syndrome was used as a model of TD to examine the ability of increased neuroleptic doses to produce long-term suppression of dyskinetic movements. The incidence and persistence of the VCM syndrome in individual rats were also assessed to look for affected and unaffected subgroups. Rats were initially treated for 15 weeks with haloperidol decanoate. For the next 21 weeks, half the group received a 50-150% increase in dose while the other half continued to receive the same dose. Animals were also followed during a 28-week withdrawal period. Total VCM ratings showed a skewed distribution, with some rats exhibiting few movements while others developed marked and persistent movements. Increasing doses did not suppress VCMs, nor did they exacerbate movements during the withdrawal period. To the extent that the VCM syndrome models TD, the absence of long-term suppression of the VCM syndrome suggests that, at this dosage range, increasing depot neuroleptic doses may not be a useful long-term strategy for TD suppression.

AB - Rats treated chronically with neuroleptics develop vacuous chewing movements (VCMs), similar in some respects to tardive dyskinesia (TD) in man. The VCM syndrome was used as a model of TD to examine the ability of increased neuroleptic doses to produce long-term suppression of dyskinetic movements. The incidence and persistence of the VCM syndrome in individual rats were also assessed to look for affected and unaffected subgroups. Rats were initially treated for 15 weeks with haloperidol decanoate. For the next 21 weeks, half the group received a 50-150% increase in dose while the other half continued to receive the same dose. Animals were also followed during a 28-week withdrawal period. Total VCM ratings showed a skewed distribution, with some rats exhibiting few movements while others developed marked and persistent movements. Increasing doses did not suppress VCMs, nor did they exacerbate movements during the withdrawal period. To the extent that the VCM syndrome models TD, the absence of long-term suppression of the VCM syndrome suggests that, at this dosage range, increasing depot neuroleptic doses may not be a useful long-term strategy for TD suppression.

KW - Haloperidol

KW - Rats

KW - Tardive dyskinesia

KW - Vacuous chewing movements

UR - http://www.scopus.com/inward/record.url?scp=0028942084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028942084&partnerID=8YFLogxK

U2 - 10.1007/BF02245101

DO - 10.1007/BF02245101

M3 - Article

C2 - 7724705

AN - SCOPUS:0028942084

VL - 117

SP - 74

EP - 81

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 1

ER -